Armagen

View All

Hunter Syndrome Market
Hunter Syndrome Market experiences a positive push as the pharma companies spot the untapped opportunities

The Hunter Syndrome Market is expected to grow with CAGR of 7.5% in the coming years in the 7MM. Occurring in approximately 1 in 100,000 to 1 in 170,000 male births, Hunter Syndrome, is an X-linked disorder, of carbohydrate metabolism that occurs almost exclusively in males, with females as the carriers of the d...

Find More

Mucopolysaccharidosis
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) – a lesser developed window

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) – a lesser developed window Mucopolysaccharidosis (MPS) is a group of rare, hereditary and incurable “storage diseases”, which is named after mucopolysaccharides (sugars bound to proteins). The stored mucopolysaccharides are called as glycosaminoglycans (GAGs). ...

Find More